The human homologue of the Drosophila discs large tumor suppressor gene (hDlg) is a member of the membrane-associated guanylate kinase family with three PSD-95/Dlg/ZO-1 (PDZ) domains. hDlg has been shown to bind tumor suppressor proteins, adenomatous polyposis coli (APC) and protein tyrosine phosphatase and tensin homologue (PTEN), and several viral oncoproteins, and has been implicated in the negative regulation of cell proliferation. hDlg has furthermore been shown to localize at the plasma membrane of synapses and to scaffold cell surface receptors and channels. In epithelial cells, hDlg localizes at the basolateral plasma membrane, but its localization mechanism is unknown. We searched here for a transmembrane protein that directly bound to hDlg. hDlg bound tumor endothelial marker 5 (TEM5), a sevenpass transmembrane protein that is homologous to the family B of G-protein-coupled receptors (GPCRs). TEM5 has previously been reported to display elevated expression during tumor angiogenesis and neoangiogenesis. The PDZ domains of hDlg bound the C-terminal PDZ-binding motif of TEM5. The expression of TEM5 was detected in endothelial cells of embryonic liver, where hDlg colocalized with TEM5. hDlg furthermore bound a novel sevenpass transmembrane protein, which was homologous to TEM5, and was named here a TEM5-like protein (TEM5-like). These results suggest that hDlg localizes at the plasma membrane through TEM5 and TEM5-like and furthermore scaffolds these GPCRs in endothelial cells during tumor angiogenesis and neoangiogenesis.
Introduction
The Drosophila discs large tumor suppressor gene, Dlg, is originally identified as the gene causing neoplastic overgrowth of the imaginal discs, and plays an important role in cell polarization and cell proliferation in Drosophila (Humbert et al., 2003) . Dlg belongs to the membrane-associated guanylate kinase (MAGUK) family (Woods and Bryant, 1991; Woods et al., 1996) , which functions as scaffolding molecules at the sites of membrane specializations, linking transmembrane proteins to signal transduction pathways and to the cytoskeleton (Dimitratos et al., 1999) . Dlg is composed of three PSD95/Dlg/ZO-1 (PDZ) domains, followed by one Src homology-3 (SH3) domain and one guanylate kinase-like (GK) domain. These domains allow Dlg to perform the scaffolding function by recruiting a distinct set of signaling and cytoskeletal components into a multimolecular protein complex. PDZ domains bind conserved C-terminal ends of many integral membrane proteins, which are target motifs characterized by a Cterminal hydrophobic residue and a free carboxylate group at the À2 position (-X-T/S-X-V/L) (Pawson and Scott, 1997) . Dlg binds Shaker-type K þ channels and fascilin II, a cell-adhesion molecule, via its PDZ domains at the larval body wall neuromuscular junctions (Tejedor et al., 1997; Thomas et al., 1997) . Scaffolding of the Shaker-type K þ channels and fascillin II by Dlg plays essential roles in organization of synaptic junctions (Budnik, 1996; Tejedor et al., 1997; Thomas et al., 1997) .
The human homologue of Dlg (hDlg) has the same domain structure as that of Dlg (Lue et al., 1994) . The PDZ domains of hDlg interact with tumor suppressor proteins, adenomatous polyposis coli (APC) and protein tyrosine phosphatase and tensin homologue (PTEN), and several viral oncoproteins such as the E6 protein of oncogenic human papillomavirus (Humbert et al., 2003) . It has been reported that overexpression of hDlg in fibroblasts leads to an impaired G1-S phase progression and inhibition of cell proliferation (Ishidate et al., 2000) . Thus, hDlg, like Dlg, is likely to be involved in the negative regulation of cell proliferation. Furthermore, hDlg directly binds alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors and Shaker-type K þ channels via its PDZ domain and scaffolds them at synapses (Kim et al., 1995; Kim and Sheng, 1996; Leonard et al., 1998; Cai et al., 2002) . hDlg binds Shaker-type K þ channels in T lymphocytes and cardiac myocytes (Hanada et al., 1997; Murata et al., 2001) . Since hDlg is ubiquitously expressed, hDlg may scaffold other molecules in other cell types (Lue et al., 1994) . In epithelial cells, hDlg localizes at cell-cell junctions (Matsumine et al., 1996; Reuver and Garner, 1998; Ide et al., 1999) . Thus, hDlg may be involved in the localization of some transmembrane proteins at the cell-cell junctions in epithelial cells. Conversely, a transmembrane protein may regulate the localization of hDlg at cell-cell junctions. Although it has been suggested that E-cadherin is involved in the localization of hDlg at the cell-cell adhesion sites (Reuver and Garner, 1998) , it remains unknown how the localization of hDlg is determined.
In this study, we searched for a transmembrane protein(s) that directly bound to hDlg. We found that hDlg bound seven-pass transmembrane proteins, tumor endothelial marker 5 (TEM5) (Carson-Walter et al., 2001 ) and a novel protein homologous to TEM5, named here a TEM5-like protein (TEM5-like). They shared homology with the family B of G-protein-coupled receptors (GPCRs) (Ji et al., 1998; Bockaert and Pin, 1999) . hDlg colocalized with TEM5 in endothelial cells of embryonic liver. Our results suggest that hDlg localizes at the plasma membrane through TEM5 and TEM5-like and furthermore scaffolds these GPCRs.
Results

Identification of TEM5 as an hDlg-binding protein
To identify a transmembrane protein(s) that binds to hDlg, we screened a human heart library by the yeast two-hybrid system using hDlg as a bait. In all, 11 different clones were isolated and one of them was identified to be TEM5, which had already been reported as a tumor endothelial marker (Carson-Walter et al., 2001) . TEM5 is a seven-pass transmembrane protein that is homologous to the family B of GPCRs ( Figure 1a) . We focused on TEM5, since all the other clones did not encode transmembrane proteins. In the course of molecular cloning of TEM5, we found that the previously reported sequence of TEM5 lacked initial seven amino acids (aa) (see Materials and methods). The corrected N-terminal sequence of TEM5 can be accessed through GenBank/EMBL/DDBL Accession no. AY090637. TEM5 consists of 1338 aa with a calculated M r of 142 593 ( Figure 1b ) and contains four leucine-rich repeats (LRRs), one LRR of the C-terminal type, one immunoglobulin-type domain, one hormone receptor domain, and one GPCR proteolysis site (GPS), in the Nterminal extracellular region (Figure 1a) .
To confirm the binding of TEM5 to hDlg, immunoprecipitation analysis was performed. A FLAG-tagged C-terminal tail of TEM5 containing the last 270 aa (FLAG-TEM5-1) and enhanced green fluorescent protein (EGFP)-tagged full-length hDlg (GFP-hDlg-1) were coexpressed in HEK293 cells. FLAG-TEM5-1 was immunoprecipitated from the cell extract with the anti-FLAG antibody (Ab), and then the immunoprecipitate was subjected to SDS-polyacrylamide gel electrophoresis (PAGE), followed by Western blotting with the anti-GFP Ab and the anti-FLAG Ab or protein staining with Coomassie brilliant blue (Figure 2Aa ). GFP-hDlg-1 was coimmunoprecipitated with FLAG-TEM5-1. To examine whether TEM5 binds to endogeneous hDlg, FLAG-TEM5-1 was expressed in COS7 cells and then FLAG-TEM5-1 was immunoprecipitated from the cell extract with the anti-FLAG Ab. The immunoprecipitate was subjected to SDS-PAGE, followed by Western blotting with the anti-hDlg Ab (Figure 2Ab ). Endogenous hDlg was coimmunoprecipitated with FLAG-TEM5-1. These results indicate that TEM5 binds to hDlg.
Direct binding of TEM5 to the PDZ domains of hDlg
The C-terminal four aa of TEM5 are ETTV, which are consistent with the PDZ-binding tetrapeptide consensus motif (-X-T/S-X-V/L) (Pawson and Scott, 1997) ( Figure 1b) . Therefore, we examined by immunoprecipitation analysis whether the C-terminal four aa of TEM5 is necessary for its binding to hDlg. C-Terminal four aa-deleted FLAG-TEM5-1 (FLAG-TEM5-2) and GFP-hDlg-1 were coexpressed in HEK293 cells. FLAG-TEM5-2 was immunoprecipitated from the cell extract with the anti-FLAG Ab, and the immunoprecipitate was subjected to SDS-PAGE, followed by Western blotting with the anti-GFP Ab (Figure 2Aa ). GFP-hDlg-1 was not coimmunoprecipitated with FLAG-TEM5-2. FLAG-TEM5-2 was also immunoprecipitated from the cell extract of COS7 cells expressing FLAG-TEM5-2 with the anti-FLAG Ab (Figure 2Ab ). Endogeneous hDlg was not coimmunoprecipitated with FLAG-TEM5-2. These results indicate that the C-terminal four aa of TEM5 is critical for its binding to hDlg.
To determine which region of hDlg binds TEM5, we prepared two deletion mutants of hDlg: a C-terminal fragment containing the SH3 and GK domains (hDlg-2) and a fragment containing the three PDZ domains (hDlg-3) (Figure 3a) . FLAG-TEM5-1 was coexpressed in HEK293 cells with GFP-hDlg-1, EGFP-tagged hDlg-2 (GFP-hDlg-2), or EGFP-tagged hDlg-3 (GFP-hDlg-3), and then FLAG-TEM5-1 was immunoprecipitated from each cell extract with the anti-FLAG Ab (Figure 3b ). GFP-hDlg-1 and GFP-hDlg-3, but not GFP-hDlg-2, were coimmunoprecipitated with FLAG-TEM5-1. These results indicate that TEM5 binds to the PDZ domains of hDlg.
To confirm the direct binding of hDlg to TEM5, we performed affinity chromatography using pure recombinant proteins of hDlg and TEM5 (Figure 4a ). An immobilized maltose-binding protein (MBP)-fusion protein of hDlg-3 (MBP-hDlg-3) directly bound a glutathione S-transferase (GST)-fusion protein of the C-terminal tail of TEM5 containing the last 190 aa (GST-TEM5-C.C). Taken together, these results indicate that TEM5 directly binds to the PDZ domains of hDlg via its C-terminal four aa.
Colocalization of TEM5 with hDlg in endothelial cells
We examined the tissue distribution of the TEM5 mRNA by Northern blotting. Northern blotting using the TEM5 cDNA as a probe detected an about 6.0-kb mRNA of TEM5 in various human tissues ( Figure 5a ). The TEM5 mRNA was abundantly expressed in the heart, placenta, prostate, ovary, small intestine, and colon. Long exposure of the hybridized membrane revealed the expression of the TEM5 mRNA in all the human tissues examined (data not shown). We next examined the tissue and subcellular localization of the TEM5 protein. For this purpose, a rabbit polyclonal Both FLAG-TEM5-1 and GFP-hDlg-1 or both FLAG-TEM5-2 and GFPhDlg-1 were coexpressed in HEK293 cells by transfection with both pFLAG-CMV2-TEM5-1 and pEGFP-C2-hDlg-1 or both pFLAG-CMV2-TEM5-2 and pEGFP-C2-hDlg-1, respectively. FLAG-TEM5-1 and FLAG-TEM5-2 were immunoprecipitated from each cell extract with the anti-FLAG Ab. Each immunoprecipitate was subjected to SDS-PAGE, followed by Western blotting using the anti-GFP or anti-FLAG Ab or by protein staining with Coomassie brilliant blue. (Ab) Immunoprecipitation from COS7 cells. FLAG-TEM5-1 or FLAG-TEM5-2 was expressed in COS7 cells. FLAG-TEM5-1 and FLAG-TEM5-2 were immunoprecipitated from each cell extract with the anti-FLAG Ab. Each immunoprecipitate was subjected to SDS-PAGE, followed by Western blotting using the anti-hDlg or anti-FLAG Ab. hDlg refers to the simian orthologue of hDlg. (B) Binding of the cytoplasmic region of TEM5-like to hDlg. FLAG-TEM5-like-1 or FLAG-TEM5-like-2 was expressed in COS7 cells. FLAG-TEM5-like-1 and FLAG-TEM5-like-2 were immunoprecipitated from each cell extract with the anti-FLAG Ab. Each immunoprecipitate was subjected to SDS-PAGE, followed by Western blotting using the anti-hDlg or anti-FLAG Ab. hDlg refers to the simian orthologue of hDlg Direct binding of hDlg to TEM5 and TEM5-like proteins Y Yamamoto et al anti-TEM5 Ab was generated. This anti-TEM5 Ab specifically recognized FLAG-tagged TEM5 exogeneously expressed in HEK293 cells (Figure 6a ). Western blotting using the anti-TEM5 Ab did not detect any significant immunoreactive bands for TEM5 in various adult mouse tissues examined including the heart, brain, lung, liver, skeletal muscle, kidney, testis, spleen, and small intestine (data not shown). It has previously been shown by in situ hybridization analysis that TEM5 is abundantly expressed in vasculature of developing embryo and tumor vessels (Carson-Walter et al., 2001) . Therefore, we performed immunostaining of TEM5 using mouse embryonic liver (E15.5). Coimmunostaining of TEM5 and CD31, a platelet endothelial cell adhesion molecule (Baldwin et al., 1994) that is a typical endothelial marker, showed that TEM5 was expressed in endothelial cells, consistent with the previous report (Carson-Walter et al., 2001) (Figure 6b ). When the anti-TEM5 Ab was preincubated with an excess amount of GST fusion protein of TEM5, the signals for TEM5 disappeared (data not shown). Therefore, the signals detected with the anti-TEM5 Ab were considered to be specific. hDlg was stained in all the cells of the embryonic liver and colocalized with TEM5 in the endothelial cells (Figure 6b ). These results indicate that hDlg colocalizes with TEM5 in endothelial cells of embryonic liver. were separately immobilized on amylose resin beads. The immobilized beads were incubated with GST-TEM5-C.C (1 nmol). After the beads were extensively washed, the bound proteins were eluted. The samples were subjected to SDS-PAGE, followed by protein staining with Coomassie brilliant blue. (b) Direct binding of TEM5-like to the PDZ domains of hDlg. MBP alone and MBPhDlg-3 (200 pmol each) were separately immobilized on amylose resin beads. The immobilized beads were incubated with GST-TEM5-like-1 (1 nmol). After the beads were extensively washed, the bound proteins were eluted. The samples were subjected to SDS-PAGE, followed by protein staining with Coomassie brilliant blue Binding of the cytoplasmic region of TEM5 to the PDZ domains of hDlg. Both FLAG-TEM5-1 and GFP-hDlg-1, both FLAG-TEM5-1 and GFP-hDlg-2, or both FLAG-TEM5-1 and GFP-hDlg-3 were coexpressed in HEK293 cells by transfection with both pFLAG-CMV2-TEM5-1 and pEGFP-C2-hDlg-1, both pFLAG-CMV2-TEM5-1 and pEGFP-C2-hDlg-2, or both pFLAG-CMV2-TEM5-1 and pEGFP-C2-hDlg-3, respectively. FLAG-TEM5-1 was immunoprecipitated from each cell extract with the anti-FLAG Ab. Each immunoprecipitate was subjected to SDS-PAGE, followed by Western blotting using the anti-GFP or anti-FLAG Ab. 1, GFPhDlg-1; 2, GFP-hDlg-2; and 3, GFP-hDlg-3. (c) Binding of the cytoplasmic region of TEM5-like to the PDZ domains of hDlg. Both FLAG-TEM5-like-1 and GFP-hDlg-2, or both FLAG-TEM5-like-1 and GFP-hDlg-3, were coexpressed in HEK293 cells by transfection with both pFLAG-CMV2-TEM5-like-1 and pEGFP-C2-hDlg-2, or both pFLAG-CMV2-TEM5-like-1 and pEGFP-C2-hDlg-3, respectively. FLAG-TEM5-like-1 was immunoprecipitated from each cell extract with the anti-FLAG Ab. Each immunoprecipitate was subjected to SDS-PAGE, followed by Western blotting using the anti-GFP or anti-FLAG Ab. 2, GFPhDlg-2; and 3, GFP-hDlg-3 Since TEM5 directly binds to the PDZ domains of hDlg via its C-terminal four aa, we next examined whether the C-terminal four aa of TEM5 is necessary and/or sufficient for its colocalization with hDlg. For this purpose, we constructed the nectin-2/TEM5 chimera protein (nectin-2-TEM5-1), the fragment of nectin-2 containing the extracellular and transmembrane domains, which is fused to the C-terminal tail of TEM5 containing the last 190 aa. Nectin-2 is a Ca 2 þ -independent immunoglobulin-like cell-cell adhesion molecule (Takai et al., 2003) . We also constructed the C-terminal four aa-deleted version of nectin-2-TEM5-1, nectin-2-TEM5-2. When these proteins were expressed in L cells, they were sorted into the plasma membrane and the extracellular domain of nectin-2 formed cell-cell adhesion (Figure 7) . Endogenous hDlg was concentrated at the nectin-2-based cell-cell adhesion sites and colocalized with nectin-2-TEM5-1 in L cells expressing nectin-2-TEM5-1 (Figure 7) . However, hDlg was not concentrated at the nectin-2-based cell-cell adhesion sites in L cells expressing nectin-2-TEM5-2 (Figure 7) . These results indicate that TEM5 recruits hDlg to the plasma membrane, and that the C-terminal four aa of TEM5 is necessary for its colocalization with hDlg.
Identification of TEM5-like as an hDlg-binding protein
We identified a cDNA fragment that encodes a protein similar to the C-terminal region of TEM5 in another two-hybrid screening using mLin-7 as a bait (data not shown). We obtained the full-length aa sequence by using the Celera Discovery System, and found that its domain structure was similar to that of TEM5 (Figure 1a) . We named this protein TEM5-like. TEM5-like consists of 1205 aa with a calculated M r of 134 821 (Figure 1b) . TEM5-like is also a seven-pass transmembrane protein that is homologous to the family B of GPCRs and contains one LRR, one LRR of the C-terminal type, one immunoglobulin-type domain, one hormone receptor domain, and one GPS, in the N-terminal extracellular region (Figure 1a) . The sequences of the C-terminal 10 aa are highly conserved between TEM5 and TEM5-like, and the last four aa of TEM5-like are ETTV (Figure 1b) . Therefore, we examined by immunoprecipitation analysis whether TEM5-like also binds to hDlg. A FLAG-tagged C-terminal tail of TEM5-like containing the last 245 aa (FLAG-TEM5-like-1) or C-terminal four aa-deleted FLAG-TEM5-like-1 (FLAG-TEM5-like-2) was expressed in COS7 cells, and then FLAG-TEM5-like-1 and FLAG-TEM5-like-2 were immunoprecipitated from each cell extract with the anti-FLAG Ab ( Figure 2B ). Endogeneous hDlg was immunoprecipitated with FLAG-TEM5-like-1, but not with FLAG-TEM5-like-2. These results indicate that TEM5-like binds to hDlg and that the C-terminal four aa of TEM5-like are critical for its binding to hDlg. We next determined which region of hDlg binds to TEM5- like. GFP-hDlg-2 and FLAG-TEM5-like-1, or GFPhDlg-3 and FLAG-TEM5-like-1 were coexpressed in HEK293 cells, and then FLAG-TEM5-like-1 was immunoprecipitated from each cell extract with the anti-FLAG Ab (Figure 3c ). GFP-hDlg-3, but not GFPhDlg-2, was coimmunoprecipitated with FLAG-TEM5-like-1. These results indicate that TEM5-like binds to the PDZ domains of hDlg. The direct binding of TEM5-like to the PDZ domains of hDlg was confirmed by affinity chromatography (Figure 4b ). Immobilized MBP-hDlg-3 bound a GST-fusion protein of TEM5-like-1 (GST-TEM5-like-1). Taken together, these results indicate that TEM5-like directly binds to the PDZ domains of hDlg via its C-terminal four aa.
Tissue distribution of TEM5-like
We examined the tissue distribution of the TEM5-like mRNA by Northern blotting. Northern blotting using the TEM5-like cDNA as a probe detected an about 5.5-kb mRNA of TEM5-like in all the human tissues examined (Figure 5b ). The expression of the TEM5-like mRNA was low in the heart, placenta, and small intestine, and was high in the skeletal muscle, prostate, testis, and colon. The difference between the level of the TEM5-like mRNA and that of the TEM5 mRNA was remarkable in the testis and skeletal muscle. These results indicate that TEM5-like is expressed in various tissues.
To address a possible role of TEM5-like protein in tumors, the expression of TEM5-like in various tumors was determined and compared to that of TEM5 (Table 1) . For this purpose, we performed real-time quantitative reverse transcriptase/polymerase chain reaction (RTQ-RT-PCR) on commercially available human tumor tissue cDNA panels. TEM5-like was more abundantly expressed in human tumors of the brain, breast, and small intestine. TEM5 was more abundantly expressed in human tumors of the breast, uterus, and liver. In most of the tissues, TEM5-like was more abundantly expressed than TEM5. These results indicate that TEM5 and TEM5-like are differently expressed in various tumors.
Discussion
hDlg is the human homologue of the Drosophila tumor suppressor gene Dlg and has been suggested to have a negative role in cell proliferation (Ishidate et al., 2000; Humbert et al., 2003) . In the present study, we have shown that TEM5 directly binds to the PDZ domains of hDlg via its C-terminal four aa, and that TEM5 colocalizes with hDlg in endothelial cells of mouse embryonic liver. Exogenously expressed TEM5 recruits hDlg to the plasma membrane and the C-terminal four aa of TEM5 is necessary for its colocalization with hDlg. TEM5 is a seven-pass transmembrane protein, which is originally isolated as a tumor endothelial marker (Carson-Walter et al., 2001) . It has been reported that the expression of TEM5 is induced during tumor angiogenesis and neoangiogenesis (Carson-Walter et al., 2001) . Taken together, our present findings suggest that hDlg is recruited to the plasma membrane by TEM5 and scaffolds it in endothelial cells during tumor angiogenesis and neoangiogenesis. It is known that hDlg scaffolds some receptors and ion channels in neurons, T lymphocytes, and cardiac myocytes (Kim et al., 1995; Kim and Sheng, 1996; Hanada et al., 1997; Leonard et al., 1998; Murata et al., 2001; Cai et al., 2002) , but the function of hDlg in endothelial cells has not yet been reported. This is the first identification of the transmembrane protein, which binds to hDlg, in endothelial cells. The role of the binding of hDlg to TEM5 during tumor angiogenesis and neoangiogenesis remains to be elucidated, but TEM5 may promote cell proliferation by anchoring hDlg, a possible negative regulator of cell proliferation, at the plasma membrane. We have also found here another novel seven-pass transmembrane protein homologous to TEM5 and named it TEM5-like. The C-terminal 10 aa are highly conserved between TEM5-like and TEM5. During the preparation of this manuscript, another group also found TEM5-like by searching the Celera database and named it GPR125 (Fredriksson et al., 2003) . In their paper, both TEM5-like/GPR125 and TEM5/GPR124 are reported as members of the superfamily of human GPCRs. Tissue distribution of TEM5 and TEM5-like is just suggested by searching human EST sequences (Fredriksson et al., 2003) . However, no functional analysis of these proteins has been performed. We have shown that TEM5-like as well as TEM5 binds to the PDZ domains of hDlg via its C-terminal four aa. Our results suggest that hDlg scaffolds both TEM5 and TEM5-like. We have also shown distribution of the TEM5 and TEM5-like mRNAs in normal and tumor tissues by Northern blotting and RTQ-RT-PCR. Thus, TEM5-like may function with hDlg in cells other than endothelial cells. The gene expressions are shown as normalized units in relation to the housekeeping gene expression of GAPDH
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Both TEM5 and TEM5-like have significant sequence similarity within the membrane-spanning regions and intervening loops to the family B of GPCRs (Stacey et al., 2000) . The family B of GPCRs binds to a number of peptide hormones, causing activation of intracellular heterotrimeric G proteins and subsequent activation of adenylate cyclase and inositol phosphate signaling cascades (Ji et al., 1998) . hDlg may play roles in signal transduction mediated by TEM5 and TEM5-like, although it remains unknown whether they function as GPCRs. Both TEM5 and TEM5-like have LRRs, an LRR of the C-terminal type, an immunoglobulin-type domain, a hormone receptor domain, and a GPS domain in their N-terminal extracellular regions. Immunoglobulin-type domains are found in a number of cell-surface molecules known to mediate cell adhesion (Chothia and Jones, 1997) . Therefore, the TEM5-hDlg complex and the TEM5-like-hDlg complex may play dual roles in signal transductions and cell adhesion.
hDlg localizes at cell-cell adhesion sites (Matsumine et al., 1996; Reuver and Garner, 1998; Ide et al., 1999) . Cell adhesion molecules interact directly or indirectly with many junction-associated proteins and regulate their localization. We have observed that hDlg is recruited to the nectin-based, E-cadherin-based, claudin-based, and JAM-based cell-cell junctions, in L fibroblasts (Fukuhara et al., manuscript in preparation). One possible explanation for this phenomenon is that an unknown transmembrane protein(s), which is endogenously expressed in L fibroblasts, recruits hDlg to the cell-cell junctions. TEM5 and TEM5-like may be candidates of such transmembrane proteins. Further studies are necessary to clarify the physiological roles of TEM5 and TEM5-like.
Materials and methods
Yeast two-hybrid screening
A bait vector, pBTM116HA-hDlg, was constructed by subcloning full-length hDlg into pBTM116HA (Fujiwara et al., 1998) . A human heart yeast two-hybrid library was purchased from CLONTECH and screened as described (Takeuchi et al., 1997) .
Cloning of cDNAs
A full-length cDNA of TEM5 was obtained by screening a human heart library in lZAPII (Stratagene, La Jolla, CA, USA). The obtained full-length cDNA encoded TEM5 consisted of 1338 aa. It had been reported that TEM5 consists of 1331 aa (GenBank/EMBL/DDBL Accession no. AY378755). Comparison between the obtained sequence and the previously reported one indicated that the previously reported aa sequence of TEM5 lacked initial seven aa. Therefore, we registered the corrected N-terminal sequence of TEM5 (GenBank/EMBL/DDBL Accession no. AY090637). A cDNA fragment of TEM5-like encoding the last 245 aa (GenBank/EMBL/DDBL Accession no. AY360366) was obtained from a human testis library (CLONTECH). Its full-length nucleotide and aa sequences were obtained using the Celera Discovery System (hCT31769 and hCP50247, respectively).
Construction of expression vectors
Various prokaryote and eukaryote expression vectors were constructed in pFLAG-CMV2, pFLAG-CMV1 (Sigma), pEGFP-C2 (CLONTECH), pMAL-c2 (NEW ENGLAND BIOLAB Inc.), pGEX-KG, and pGEX-4T-1 (Amersham Biosciences Inc.). pFLAG-CMV2 and pEGFP-C2 were designed to express an N-terminal FLAG-tagged protein and an N-terminal EGFP-tagged protein, respectively. Various constructs of hDlg, TEM5, and TEM5-like contained the following aa: pEGFP-hDlg-1, aa 1-926 (full length); pEGFPhDlg-2, aa 560-926 (SH3 and GK domains); pEGFP-hDlg-3, pMAL-c2-hDlg-3, and pBTM116HA-hDlg-3, aa 220-559 (three PDZ domains); pFLAG-CMV1-TEM5, aa 35-1338; pFLAG-CMV2-TEM5-1, aa 1068-1338; pFLAG-CMV2-TEM5-2, aa 1068-1338; pGEX-KG-TEM5-TM5/6, aa 946-1010 (cytoplasmic region between the fifth and sixth transmembrane domains); pGEX-KG-TEM5-C.C, aa 1145-1338; pFLAG-CMV1-TEM5-like-1 and pGEX-4T-1-TEM5-like-1, aa 960-1205; and pFLAG-CMV1-TEM5-like-2, aa 960-1201. The construct of pFLAG-CMV1-nectin-2/TEM5-1 contained the cDNA fragment encoding the extracellular and transmembrane domains of mouse nectin-2 (aa 1-394) fused to the cytoplasmic domain of TEM5 (aa 1062-1331). pFLAG-CMV1-nectin-2/TEM5-2 is the terminal four aa-deleted version of pFLAG-CMV1-nectin-2-TEM5-1.
Antibodies
A rabbit antiserum against TEM5 was raised against GST-TEM5-TM5/6. This antiserum was affinity-purified with GST-TEM5-TM5/6 covalently coupled to NHS-activated Sepharose beads (Amersham Biosciences Inc.). An obtained Ab was used as a polyclonal anti-TEM5 Ab. A mouse monoclonal anti-PSD-95 family Ab, a mouse monoclonal anti-CD31 Ab, a mouse monoclonal anti-FLAG M2 Ab, and a mouse monoclonal anti-GFP Ab were purchased from Upstate Biotechnology, BD Biosciences, SIGMA, and CLONTECH, respectively. The anti-PSD-95 family Ab was used as an anti-hDlg Ab.
Cell culture and transfection COS7, HEK293, and L cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal calf serum. COS7 and HEK293 cells were transfected with the calcium phosphate method using CalPhos Transfection Kit (CLONTECH). L cells expressing pFLAG-CMV1-nectin-2/TEM5-1 and pFLAG-CMV1-nectin-2/TEM5-2 were prepared using LIPO-FECTAMINE 2000 (Invitrogen) .
Immunoprecipitation
The cells transfected with appropriate vectors were suspended in a lysis buffer (20 mM Tris-HCl at pH 7.5, 150 mM NaCl, 1% (w/v) Triton X-100, and 1 mM EDTA) containing protease inhibitors (20 mg/ml leupeptin, 1 mg/ml pepstatin A, and 1 mM PMSF) and then sonicated on ice. The cell extract, obtained by centrifugation at 100 000 g for 1 h, was incubated with an anti-FLAG M2 Ab at 41C for 3 h. Protein G-Sepharose 4 Fast Flow beads (20 ml of wet volume) were added to this sample, and incubation was performed at 41C for 1 h. After the beads were washed with the lysis buffer, the bound proteins were eluted by boiling the beads in an SDS sample buffer for 10 min. The sample was subjected to SDS-PAGE, followed by protein staining with Coomassie brilliant blue or by Western blotting using the anti-FLAG, anti-GFP, or anti-hDlg Ab.
Affinity chromatography
MBP-hDlg-3 and MBP alone (200 pmol each) were separately immobilized on amylose resin beads (20 ml of wet volume) (NEW ENGLAND BIOLAB Inc.). GST-TEM5-C.C, GST-TEM5-like-1, or GST alone (1 nmol each) was incubated with the immobilized beads in 1 ml of Buffer A (20 mM Tris-HCl at pH 7.5 and 150 mM NaCl) at 41C for 3 h. After the beads were extensively washed with Buffer A, elution was performed by boiling the beads in an SDS sample buffer for 10 min. Each sample was subjected to SDS-PAGE, followed by protein staining with Coomassie brilliant blue.
Immunofluorescence microscopy
A mouse embryonic liver (E15.5) was fixed with PBS containing 2% paraformaldehyde at 41C for 4 h and then incubated in PBS containing 10% sucrose at 41C overnight. After subsequent incubation in PBS containing 25% sucrose at 41C for 2 h, the sample was frozen using liquid nitrogen. The frozen sections (10 mm) were cut in a cryostat. The samples were mounted on glass slides and air-dried. After the samples were soaked in PBS containing 10% BlockAce (DAINIPPON PHARMACEUTICAL CO., LTD.) and 0.005% saponin, the samples were incubated with both the anti-TEM5 Ab and the anti-PSD-95 family Ab or both the anti-TEM5 Ab and the anti-CD31 Ab. The samples were then washed with PBS containing 0.005% saponin, followed by incubation with FITC-conjugated sheep anti-rabbit IgG and rhodamineconjugated donkey anti-mouse IgG Abs. After being washed with PBS containing 0.005% saponin, they were embedded and viewed with a confocal imaging system (Radiance 2100; Bio-Rad Laboratories, Hercules, CA, USA).
RTQ-RT-PCR
Primers and probes for TaqMan assays were designed using the Primer Express software program (ABI, Foster City, CA, USA), and were purchased from ABI. TaqMan probes were labeled at the 5 0 end with 6-carboxy-fluorescein and at the 3 0 end with the fluorescence quencher 6-carboxy-tetramethylrhodamine. The sequences of the primers and probes for assays specific for TEM5 and TEM5-like are follows.
TEM5 forward primer; CGTCCAAGCCTTGGCG TEM5 reverse primer; CGCACAGGAAATAGATCCAGG TEM5 probe; ACATCCCTGTGGCTTTGATTC-TGCTCA TEM5-like forward CGTGCAGAACGGCTTACCTAA primer; TEM5-like reverse GCTCTTCGGCTCCTCGAGT primer; TEM5-like probe; AGCCGGCTGGGCAATAAC-GAAGG TaqMan GAPDH control reagents (ABI) were used as a control for the amount of cDNA. For RTQ-RT-PCR, 1 ml of undiluted human tumor tissue panel cDNA (purchased from Biochain) was added to 50 ml of PCR reaction buffer, which contained 900 nM each of the forward and reverse primers and 100 nM of fluorescence-labeled probe in TaqMan Universal master mixture reagent (ABI). Samples were incubated at 501C for 5 min and at 951C for 10 min, after which target amplification was carried out through 45 two-staged cycles with at 951C for 15 s and at 601C for 1 min in an ABI Prism 7700 Sequence Detection System (ABI). For each data point, duplicate samples were analysed in parallel, and all assays were repeated with highly reproducible results. All results shown in this report represent the averages of these four measurements.
Miscellaneous procedures
Protein concentrations were determined with bovine serum albumin as a reference protein (Bradford, 1976) . SDS-PAGE was carried out as described (Laemmli, 1970) . Northern blotting was performed using multiple tissue Northern blots (CLONTECH).
Abbreviations aa, amino acid(s); Ab, antibody; EGFP, enhanced green fluorescent protein; GK, guanylate kinase-like; GPCR, Gprotein-coupled receptor; GPS, GPCR proteolysis site; GST, glutathione S-transferase; hDlg, human homologue of the Drosophila discs large tumor suppressor; LRR, leucine-rich repeat; MAGUK, membrane-associated guanylate kinase homologue; MBP, maltose-binding protein; PDZ, PSD-95/ Dlg/ZO-1; RTQ-RT-PCR, real-time quantitative reverse transcriptase/polymerase chain reaction; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; SH3, Src homology-3; TEM5, tumor endothelial marker 5.
